Twincretin Shows Positive Effects in Phase 3 Trial in Diabetes ...Middle East

Medscape - News
Tirzepatide, the first dual GIP and GLP-1 receptor agonist in advanced testing, showed potent antihyperglycemic and weight loss effects in the first of several phase 3 studies in type 2 diabetes. Medscape Medical News

Hence then, the article about twincretin shows positive effects in phase 3 trial in diabetes was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Twincretin Shows Positive Effects in Phase 3 Trial in Diabetes )

Apple Storegoogle play

Last updated :

Also on site :



Latest News